Dermapharm Holding SE (DMPHF) Financial Statements
$53.00OTC: DMPHFMarket Cap $2.63B
Dermapharm Holding SE most recently reported annual revenue of $1.2B, net profit of $132.0M, revenue has compounded at 8.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.